6505--Norethindrone 5mg Tablet (VA-25-00005551)
ID: 36E79724Q0007Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    Sources Sought VETERANS AFFAIRS, DEPARTMENT OF is conducting market research for the procurement of Norethindrone Acetate Tablets. These tablets are used by the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). The procurement aims to establish a national mandatory requirements contract for these agencies. The contract will be awarded to a company offering lower than FSS/Open Market prices based on a committed volume of purchases. The contract will cover the base year and all option years. Interested companies are requested to provide information on their ability to meet the minimum requirements, including a unique NDC (Labeler Code), a letter of commitment from the manufacturer, and a business-to-business agreement with the Pharmaceutical Prime Vendor Program (PPV). The contract also requires compliance with specific product, bottle size, and packaging requirements. Responses are requested by August 1, 2024. For more information, please contact Adrienne Albachiara at adrienne.albachiara@va.gov or 708-202-9027.

    Point(s) of Contact
    Adrienne AlbachiaraContract Specialist
    (708) 202-9027
    adrienne.albachiara@va.gov
    Files
    Title
    Posted
    Lifecycle
    Title
    Type
    Similar Opportunities
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Abiraterone Acetate Tablets, identified by solicitation number 36E79724R0023. This procurement aims to secure a reliable supply of these pharmaceutical products for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare entities, emphasizing the need for uninterrupted supply and compliance with specific labeling and packaging requirements. The estimated annual requirements include 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets, with the RFP scheduled for electronic release on approximately September 18, 2024, and a closing date of October 2, 2024. Interested vendors can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247, and must regularly check SAM.gov for updates as no paper copies of the solicitation will be provided.
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) numbered 36E79724R0029 for the procurement of Bupropion Hydrochloride (HCL) Tablets. This procurement aims to ensure a consistent supply of these essential medications for various federal institutions, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract will span one year with the option for four additional one-year periods, requiring offerors to provide unique product labels and National Drug Code (NDC) numbers for the supplied items, with an estimated annual requirement of over 158,000 bottles of Bupropion tablets in different dosages. Interested parties should note that the electronic solicitation is scheduled for release around September 16, 2024, with a submission deadline of September 30, 2024. For inquiries, contact Andrew Cazares at Andrew.Cazares@va.gov or (719) 786-4990.
    6505--Levothyroxine Tablets (VA-24-00084562)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to solicit proposals for the procurement of Levothyroxine Sodium Tablets under Request for Proposal (RFP) 36E79724R0020. This procurement aims to secure an uninterrupted supply of these essential medications for various VA facilities, including Consolidated Mail Order Pharmacies, State Veterans Homes, the Indian Health Service, and the Federal Health Care Center. The contract will span one year, with the possibility of four additional pre-priced option periods, reflecting the VA's commitment to meeting the pharmaceutical needs of veterans. Interested suppliers must submit their proposals by September 30, 2024, and can direct inquiries to Contract Specialist Youlanda Duggar at Youlanda.duggar@va.gov or by phone at 708-786-4943.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Prasugrel HCL tablets in 5mg and 10mg 30-count bottles, aimed at ensuring a reliable supply for various federal health entities, including the Department of Defense (DoD) and the Bureau of Prisons (BOP). The contract will cover a period of one year with four optional one-year extensions, requiring suppliers to provide products with unique National Drug Codes (NDC) and specific packaging that includes safety caps and designated bottle dimensions. This procurement is critical for maintaining uninterrupted access to essential medications for veterans and other federal health care facilities. Interested vendors should note that the RFP is anticipated to be issued around September 17, 2024, with offers due by October 1, 2024; inquiries should be directed to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is initiating a Request for Proposal (RFP 36E79724R0028) for the procurement of Zolmitriptan Tablets, aimed at ensuring a reliable supply for various federal health entities, including the Department of Defense and the Bureau of Prisons. The procurement seeks to secure an uninterrupted source of Zolmitriptan, with estimated annual requirements of 28,339 blister packs of 2.5mg tablets and 147,600 blister packs of 5mg tablets, reflecting the critical need for this medication in treating migraines among veterans and other federal beneficiaries. The solicitation is expected to be issued electronically on or around September 5, 2024, with a submission deadline of September 19, 2024; interested vendors should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for inquiries and must have an FDA-assigned NDC number to participate.
    Norgestimate/Ethinyl Estradiol Oral Tablets
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is seeking Norgestimate/Ethinyl Estradiol Oral Tablets. These tablets are typically used for oral contraception.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.
    Repaglinide
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.
    Rabeprazole Sodium Delayed Release Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The tablets will be used for medical purposes and will be available in 30, 90, and 500 count bottles. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source to provide the tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should contact Phyllis Daraio for more information. The projected solicitation date is February 2020.
    6505--770-24-4-801-0687 - National CMOP BUDESONIDE (VA-24-00098402)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Budesonide 0.5MG/2ML Inhalation Suspension for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations. The procurement, identified by solicitation number 36C77024Q0387, requires vendors to provide specific quantities of the pharmaceutical product, adhering to safety and shipping regulations, including compliance with the Drug Supply Chain Security Act. This contract is critical for ensuring the availability of essential medications within the federal healthcare system, with proposals due by September 11, 2024, and an estimated issuance date for the request for quotes on September 6, 2024. Interested vendors must submit their proposals, including a signed SF1449 cover page, a price schedule, a valid state wholesale distributor license, and a Trade Agreements Act certificate, to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.